Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
This study aims to evaluate the effects of combined calcium and vitamin D3 supplementation on maternal, pregnancy, and neonatal outcomes.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Clinical data from 122 pregnant women were retrospectively analyzed and categorized into three groups based on their actual intake: control (n = 48), Calcium 600-Vitamin D (600 mg calcium + 1,000 IU vitamin D daily, n = 41), and Calcium 1,200-Vitamin D (1,200 mg calcium + 1,000 IU vitamin D daily, n = 33).
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
The efficacy of calcium and vitamin D3 supplementation in improving pregnancy and neonatal outcomes
Study design awaiting verification · Frontiers in Pediatrics · 2025
Original publication title
The efficacy of calcium and vitamin D3 supplementation in improving pregnancy and neonatal outcomes
© 2025 Wang, Shen, Wu, Zhang, Wang and Zhou.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
This study aims to evaluate the effects of combined calcium and vitamin D3 supplementation on maternal, pregnancy, and neonatal outcomes.
Source: ObjectiveAbstract: What methods does the paper describe?
Clinical data from 122 pregnant women were retrospectively analyzed and categorized into three groups based on their actual intake: control (n = 48), Calcium 600-Vitamin D (600 mg calcium + 1,000 IU vitamin D daily, n = 41), and Calcium 1,200-Vitamin D (1,200 mg calcium + 1,000 IU vitamin D daily, n = 33). Baseline characteristics and outcomes including gestational diabetes, preeclampsia, gestational hypertension, birth weight, and Apgar scores were collected and analyzed.
Source: MethodsAbstract: Results
Calcium and vitamin D₃ supplementation was associated with significantly lower rates of gestational diabetes (P = 0.035), preeclampsia (P = 0.032), and gestational hypertension (P = 0.047), as well as reduced leg cramp frequency (P < 0.001). Neonatal outcomes improved with higher birth weights (P < 0.001) and better 1-minute Apgar scores (P < 0.001). Multivariable logistic regression confirmed that high-dose supplementation (Calcium 1,200: Vitamin D) was independently associated with reduced risks of gestational diabetes (OR = 0.423, 95% CI: 0.123 to 0.869, P = 0.043) and gestational hypertension (OR = 0.342, 95% CI: 0.126 to 0.875, P = 0.012).
Both supplementation groups significantly reduced leg cramp frequency: Calcium 600: Vitamin D (OR = 0.507, 95% CI: 0.355 to 0.723, P < 0.001) and Calcium 1,200: Vitamin D (OR = 0.512, 95% CI: 0.256 to 0.985, P = 0.012). No significant differences were found in other outcomes including preterm birth, neonatal infection, or NICU admission (P > 0.05).
Source: ResultsAbstract: Conclusion
This study suggests that combined calcium and vitamin D₃ supplementation during pregnancy may help reduce the risk of pregnancy-related complications and improve neonatal outcomes, supporting its potential as an adjunct to prenatal care. Further large-scale and long-term studies are warranted to confirm these findings.
Source: ConclusionAuthors’ abstract
Objective
This study aims to evaluate the effects of combined calcium and vitamin D3 supplementation on maternal, pregnancy, and neonatal outcomes.
Methods
Clinical data from 122 pregnant women were retrospectively analyzed and categorized into three groups based on their actual intake: control (n = 48), Calcium 600-Vitamin D (600 mg calcium + 1,000 IU vitamin D daily, n = 41), and Calcium 1,200-Vitamin D (1,200 mg calcium + 1,000 IU vitamin D daily, n = 33). Baseline characteristics and outcomes including gestational diabetes, preeclampsia, gestational hypertension, birth weight, and Apgar scores were collected and analyzed.
Results
Calcium and vitamin D₃ supplementation was associated with significantly lower rates of gestational diabetes (P = 0.035), preeclampsia (P = 0.032), and gestational hypertension (P = 0.047), as well as reduced leg cramp frequency (P < 0.001). Neonatal outcomes improved with higher birth weights (P < 0.001) and better 1-minute Apgar scores (P < 0.001). Multivariable logistic regression confirmed that high-dose supplementation (Calcium 1,200: Vitamin D) was independently associated with reduced risks of gestational diabetes (OR = 0.423, 95% CI: 0.123 to 0.869, P = 0.043) and gestational hypertension (OR = 0.342, 95% CI: 0.126 to 0.875, P = 0.012).
Both supplementation groups significantly reduced leg cramp frequency: Calcium 600: Vitamin D (OR = 0.507, 95% CI: 0.355 to 0.723, P < 0.001) and Calcium 1,200: Vitamin D (OR = 0.512, 95% CI: 0.256 to 0.985, P = 0.012). No significant differences were found in other outcomes including preterm birth, neonatal infection, or NICU admission (P > 0.05).
Conclusion
This study suggests that combined calcium and vitamin D₃ supplementation during pregnancy may help reduce the risk of pregnancy-related complications and improve neonatal outcomes, supporting its potential as an adjunct to prenatal care. Further large-scale and long-term studies are warranted to confirm these findings.
Publication and source details
Original title: The efficacy of calcium and vitamin D3 supplementation in improving pregnancy and neonatal outcomes
Fei Wang; Mengqing Shen; Ting Wu; Yang Zhang; Yun Wang; Congyun Zhou
Frontiers in Pediatrics · 2025
Edited by: Xin Li, Sichuan University, China
Reviewed by: Zhengtao Liu, Zhejiang Shuren University, China
Mehmet Tunç, Başkent University, Türkiye
Han Zo Choi, Kyung Hee University Hospital at Gangdong, Republic of Korea
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:46:05.415110+00:00
DOI: 10.3389/fped.2025.1605489 · PMC12207317